Ipsen is a global specialty-driven pharmaceutical company focused on innovation and specialty care and committed to giving hope to patients with difficult-to-treat diseases and limited options. Our core areas of therapeutic expertise include oncology, neuroscience and rare diseases.
Meet Ed Dybka, General Manager, Ipsen Canada
Ed Dybka was appointed to the role of General Manager at Ipsen Biopharmaceuticals Canada Inc. in October 2018. In this role, he is responsible for overseeing all of Ipsen’s operations across all therapeutic areas in Canada. Ed is a member of the Ipsen North America Leadership Team and the Ipsen Global Leadership Team.
With products sold in over 115 countries, and offices in more than 30 countries, the Ipsen Group is a global specialty-driven biotechnology company that is focused on putting patients first.
Ipsen in Canada
Ipsen Canada brings a refreshing approach to innovation, research, and patient support to the Canadian pharmaceutical market. In the span of a few years, we have helped bring important medicines to Canadians living with rare and serious diseases, where limited options exist.
Our roots in Canada are relatively young – but Ipsen’s beginnings can be traced all the way back to 1929.
At Ipsen Canada, our ambition is to make medicines that make a difference; and to keep doing that, year in, year out. By working closely with like-minded industry partners, we will bring to market therapies that truly make a difference.